Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$20.68 - $39.85 $10,360 - $19,964
501 Added 2.35%
21,865 $467,000
Q1 2023

May 12, 2023

BUY
$38.82 - $54.59 $19,448 - $27,349
501 Added 2.4%
21,364 $863,000
Q4 2022

Feb 13, 2023

BUY
$40.77 - $53.73 $151,093 - $199,123
3,706 Added 21.6%
20,863 $970,000
Q3 2022

Nov 14, 2022

BUY
$48.29 - $71.27 $70,068 - $103,412
1,451 Added 9.24%
17,157 $891,000
Q2 2022

Aug 11, 2022

BUY
$38.13 - $76.93 $11,439 - $23,079
300 Added 1.95%
15,706 $742,000
Q1 2022

May 12, 2022

BUY
$56.06 - $74.11 $5,606 - $7,411
100 Added 0.65%
15,406 $1.1 Million
Q4 2021

Feb 11, 2022

SELL
$60.19 - $97.37 $911,998 - $1.48 Million
-15,152 Reduced 49.75%
15,306 $1.14 Million
Q3 2021

Nov 12, 2021

BUY
$41.02 - $58.65 $453,271 - $648,082
11,050 Added 56.94%
30,458 $1.73 Million
Q1 2021

May 13, 2021

BUY
$41.69 - $54.95 $58,324 - $76,875
1,399 Added 7.77%
19,408 $957,000
Q4 2020

Feb 10, 2021

SELL
$41.16 - $47.47 $942,522 - $1.09 Million
-22,899 Reduced 55.98%
18,009 $758,000
Q3 2020

Nov 12, 2020

BUY
$43.36 - $53.53 $1.35 Million - $1.67 Million
31,206 Added 321.65%
40,908 $1.87 Million
Q2 2020

Aug 10, 2020

BUY
$46.37 - $57.58 $449,881 - $558,641
9,702 New
9,702 $487,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $107M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.